https://www.selleckchem.com/products/th1760.html
We successfully constructed a novel ceRNA network wherein each component was significantly associated with the prognosis of LUAD. Hence, we propose that this network may provide key biomarkers or potential therapeutic targets for LUAD prognosis.This study aims to compare sleeve gastrectomy (SG) and one anastomosis gastric bypass (OAG in terms of remission of type 2 diabetes mellitus (T2DM) in obese patients. All T2DM patients were followed-up for at least 36 months. The primary outcome was remission of T2DM. Secondary endpoints include
Like
Comment
Share
